AstraZeneca Admits that Covid 19 vaccine, Covishield can cause rare side effect

Shivani Arora

Covishield was developed by AstraZeneca and was produced by the Serum Institute of India. In India, it was one of the widely administered COVID vaccine.

According to a report by The Telegraph, AstraZeneca, the company behind the Covishield vaccine, has acknowledged in court documents for the first time that the vaccine may lead to a rare side effect. It said, “It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known.” This marks a notable reversal that could lead to a multi-million pound legal payout.

According to the report, the company is being sued in a class action over claims that its vaccine can cause a health issue called Thrombosis with Thrombocytopenia Syndrome (TTS). This condition leads to blood clots forming in the body and a decrease in the number of platelets in the blood. Covishield, developed by AstraZeneca and Oxford University, was widely used during the COVID-19 pandemic, including in India where it was produced by the Serum Institute.

What is TTS?

Dr Jagadish J Hiremath, a public health intellectual, elaborates, “Thrombosis with Thrombocytopenia Syndrome (TTS) is a rare condition characterised by the formation of blood clots (thrombosis) in blood vessels and a low number of blood platelets (thrombocytopenia). It has been observed as an extremely rare adverse effect associated with certain COVID-19 vaccines, notably those that use adenovirus vectors, like the AstraZeneca vaccine (Covishield).”

Treatment for TTS involves a multidisciplinary approach, including hospitalization, anticoagulation therapy to prevent further clotting, and supportive care. Intravenous immunoglobulin (IVIG) and plasma exchange may also be utilized to stabilize platelet levels and manage immune-mediated reactions.

Share This Article
I am Shivani Arora, a media student who is working as a freelancer Content Writer, news writer and social media handler with different agencies. I am a post graduate student who is self motivated and a hardworking person. My main aim is to excel in my career by learning and exploring new things.
Leave a comment